Gregor P. Lotz

2.2k total citations
22 papers, 1.5k citations indexed

About

Gregor P. Lotz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Gregor P. Lotz has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 7 papers in Neurology. Recurrent topics in Gregor P. Lotz's work include Genetic Neurodegenerative Diseases (12 papers), Neurological disorders and treatments (6 papers) and Mitochondrial Function and Pathology (5 papers). Gregor P. Lotz is often cited by papers focused on Genetic Neurodegenerative Diseases (12 papers), Neurological disorders and treatments (6 papers) and Mitochondrial Function and Pathology (5 papers). Gregor P. Lotz collaborates with scholars based in United States, Switzerland and Germany. Gregor P. Lotz's co-authors include Paul J. Muchowski, Justin Legleiter, Wolfgang Stremmel, G Strohmeyer, Wolfgang M.J. Obermann, Hongying Lin, P D Berk, Leslie M. Thompson, Anna G. Orr and Lennart Mucke and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Gregor P. Lotz

20 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregor P. Lotz United States 16 1.0k 715 372 191 180 22 1.5k
Meng‐Chin Lin United States 18 1.2k 1.2× 479 0.7× 809 2.2× 72 0.4× 146 0.8× 28 1.7k
Cindy Voisine United States 17 1.5k 1.5× 454 0.6× 250 0.7× 186 1.0× 433 2.4× 24 2.1k
Maciej Łałowski Finland 25 1.2k 1.2× 284 0.4× 792 2.1× 122 0.6× 359 2.0× 68 2.0k
Xiaojiang Li China 14 1.7k 1.7× 1.1k 1.5× 339 0.9× 421 2.2× 198 1.1× 31 2.3k
Sven Vilain Belgium 12 748 0.7× 383 0.5× 449 1.2× 469 2.5× 225 1.3× 16 1.6k
Kaori Nishikawa Japan 23 841 0.8× 248 0.3× 259 0.7× 101 0.5× 135 0.8× 44 1.7k
Martin J. Berg United States 25 929 0.9× 454 0.6× 851 2.3× 192 1.0× 361 2.0× 48 2.0k
Lotta Agholme Sweden 15 537 0.5× 264 0.4× 592 1.6× 157 0.8× 166 0.9× 24 1.2k
Manuela Basso Italy 26 1.6k 1.6× 394 0.6× 389 1.0× 659 3.5× 203 1.1× 56 2.4k

Countries citing papers authored by Gregor P. Lotz

Since Specialization
Citations

This map shows the geographic impact of Gregor P. Lotz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor P. Lotz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor P. Lotz more than expected).

Fields of papers citing papers by Gregor P. Lotz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor P. Lotz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor P. Lotz. The network helps show where Gregor P. Lotz may publish in the future.

Co-authorship network of co-authors of Gregor P. Lotz

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor P. Lotz. A scholar is included among the top collaborators of Gregor P. Lotz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor P. Lotz. Gregor P. Lotz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lotz, Gregor P., Meret Martin‐Facklam, Eginhard Schick, et al.. (2024). Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure. Frontiers in Immunology. 15. 1406353–1406353. 1 indexed citations
2.
Tourdot, Sophie, Sofie Denies, Viswanath Devanarayan, et al.. (2024). Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals. mAbs. 16(1). 2324801–2324801.
3.
Lotz, Gregor P. & Andreas Weiss. (2013). Immuno-based Detection Assays to Quantify Distinct Mutant Huntingtin Conformations in Biological Samples. Methods in molecular biology. 1017. 163–171. 2 indexed citations
4.
Putten, Herman van der & Gregor P. Lotz. (2013). Opportunities and Challenges for Molecular Chaperone Modulation to Treat Protein-Conformational Brain Diseases. Neurotherapeutics. 10(3). 416–428. 11 indexed citations
5.
Lotz, Gregor P. & Justin Legleiter. (2013). The role of amyloidogenic protein oligomerization in neurodegenerative disease. Journal of Molecular Medicine. 91(6). 653–664. 35 indexed citations
6.
Sontag, Emily M., Gregor P. Lotz, Namita Agrawal, et al.. (2012). Methylene Blue Modulates Huntingtin Aggregation Intermediates and Is Protective in Huntington's Disease Models. Journal of Neuroscience. 32(32). 11109–11119. 78 indexed citations
7.
Sontag, Emily M., Gregor P. Lotz, Guocheng Yang, et al.. (2012). Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by Small Molecules. Journal of Huntington s Disease. 1(1). 119–132. 24 indexed citations
8.
Baldo, Barbara, Paolo Paganetti, Stephan Grueninger, et al.. (2012). TR-FRET-Based Duplex Immunoassay Reveals an Inverse Correlation of Soluble and Aggregated Mutant huntingtin in Huntington's Disease. Chemistry & Biology. 19(2). 264–275. 59 indexed citations
9.
Marcellin, David, Dorothée Abramowski, Douglas B. Young, et al.. (2012). Fragments of HdhQ150 Mutant Huntingtin Form a Soluble Oligomer Pool That Declines with Aggregate Deposition upon Aging. PLoS ONE. 7(9). e44457–e44457. 23 indexed citations
10.
Bidinosti, Michael, Derya R. Shimshek, Brit Mollenhauer, et al.. (2012). Novel One-step Immunoassays to Quantify α-Synuclein. Journal of Biological Chemistry. 287(40). 33691–33705. 39 indexed citations
11.
Chen, Xuesong, Jun Wu, Yuan Luo, et al.. (2011). Expanded Polyglutamine-Binding Peptoid as a Novel Therapeutic Agent for Treatment of Huntington's Disease. Chemistry & Biology. 18(9). 1113–1125. 39 indexed citations
12.
Legleiter, Justin, Gregor P. Lotz, Ellen Sapp, et al.. (2010). Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo. Journal of Biological Chemistry. 285(19). 14777–14790. 176 indexed citations
13.
Lotz, Gregor P., Justin Legleiter, Rebecca Aron, et al.. (2010). Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle. Journal of Biological Chemistry. 285(49). 38183–38193. 59 indexed citations
14.
Cissé, Moustapha, Brian Halabisky, Julie A. Harris, et al.. (2010). Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature. 469(7328). 47–52. 329 indexed citations
15.
Wacker, Jennifer L., San‐Yuan Huang, Andrew D. Steele, et al.. (2009). Loss of Hsp70 Exacerbates Pathogenesis But Not Levels of Fibrillar Aggregates in a Mouse Model of Huntington's Disease. Journal of Neuroscience. 29(28). 9104–9114. 90 indexed citations
16.
Legleiter, Justin, Gregor P. Lotz, Jason Miller, et al.. (2009). Monoclonal Antibodies Recognize Distinct Conformational Epitopes Formed by Polyglutamine in a Mutant Huntingtin Fragment. Journal of Biological Chemistry. 284(32). 21647–21658. 86 indexed citations
17.
Lotz, Gregor P., et al.. (2008). A novel HSP90 chaperone complex regulates intracellular vesicle transport. Journal of Cell Science. 121(5). 717–723. 39 indexed citations
18.
Lotz, Gregor P., et al.. (2003). Aha1 Binds to the Middle Domain of Hsp90, Contributes to Client Protein Activation, and Stimulates the ATPase Activity of the Molecular Chaperone. Journal of Biological Chemistry. 278(19). 17228–17235. 175 indexed citations
19.
Stremmel, Wolfgang, Gregor P. Lotz, Claus Niederau, Rolf Teschke, & G Strohmeyer. (1987). Iron uptake by rat duodenal microvillous membrane vesicles: evidence for a carrier mediated transport system. European Journal of Clinical Investigation. 17(2). 136–145. 59 indexed citations
20.
Stremmel, Wolfgang, Gregor P. Lotz, G Strohmeyer, & P D Berk. (1985). Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes.. Journal of Clinical Investigation. 75(3). 1068–1076. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng‐Chin Lin Breakdown of academic impact, for papers by Cindy Voisine Breakdown of academic impact, for papers by Maciej Łałowski Breakdown of academic impact, for papers by Xiaojiang Li Breakdown of academic impact, for papers by Sven Vilain Breakdown of academic impact, for papers by Kaori Nishikawa Breakdown of academic impact, for papers by Martin J. Berg Breakdown of academic impact, for papers by Lotta Agholme Breakdown of academic impact, for papers by Manuela Basso
Rankless by CCL
2026